Relmada Therapeutics
RLMD
#9903
Rank
A$18.37 M
Marketcap
$0.61
Share price
4.60%
Change (1 day)
-87.38%
Change (1 year)

Relmada Therapeutics (RLMD) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$12.98 Million

According to Relmada Therapeutics's latest financial reports the company's total liabilities are A$12.98 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Relmada Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$18.32 M-11.8%
2021-12-31A$20.77 M26.74%
2020-12-31A$16.39 M
2019-06-30A$3.71 M-67.9%
2018-06-30A$11.56 M545.59%
2017-06-30A$1.79 M-58.21%
2016-06-30A$4.28 M-78.9%
2015-06-30A$20.3 M-28.83%
2014-06-30A$28.53 M
2013-08-31A$0.03 M455.74%
2012-08-31A$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.61 B 4,642.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$2.32 B 17,802.37%๐Ÿ‡บ๐Ÿ‡ธ USA